Vanguard Group Inc Pro Phase Labs, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 655,947 shares of PRPH stock, worth $413,246. This represents 0.0% of its overall portfolio holdings.

Number of Shares

655,947

Previous 655,947 -0.0%

Holding current value

$413,246

Previous $2.74 Million 42.1%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.18 - $7.35 $155,429 - $273,302	37,184 Added 6.01%	655,947 $2.74 Million
Q1 2024 May 10, 2024	BUY	$4.47 - $6.47 $42,089 - $60,921	9,416 Added 1.55%	618,763 $4 Million
Q4 2023 Feb 14, 2024	BUY	$4.35 - $5.1 $32,655 - $38,285	7,507 Added 1.25%	609,347 $2.75 Million
Q2 2023 Aug 14, 2023	SELL	$7.15 - $9.78 $105,934 - $144,900	-14,816 Reduced 2.4%	601,840 $4.37 Million
Q1 2023 May 15, 2023	BUY	$6.62 - $9.57 $187,259 - $270,706	28,287 Added 4.81%	616,656 $4.7 Million
Q4 2022 Feb 10, 2023	BUY	$8.78 - $12.47 $54,084 - $76,815	6,160 Added 1.06%	588,369 $5.67 Million
Q3 2022 Nov 14, 2022	SELL	$8.96 - $14.7 $161,280 - $264,600	-18,000 Reduced 3.0%	582,209 $6.57 Million
Q2 2022 Aug 12, 2022	BUY	$6.52 - $13.24 $571,152 - $1.16 Million	87,600 Added 17.09%	600,209 $7.61 Million
Q1 2022 May 13, 2022	BUY	$6.2 - $7.87 $90,960 - $115,460	14,671 Added 2.95%	512,609 $3.59 Million
Q4 2021 Feb 14, 2022	BUY	$5.13 - $7.89 $156,957 - $241,402	30,596 Added 6.55%	497,938 $3.57 Million
Q3 2021 Nov 12, 2021	BUY	$4.89 - $7.82 $4,909 - $7,851	1,004 Added 0.22%	467,342 $2.43 Million
Q2 2021 Aug 13, 2021	BUY	$4.61 - $6.83 $2.15 Million - $3.19 Million	466,338 New	466,338 $2.89 Million

Others Institutions Holding PRPH

# of Institutions

Shares Held

1.71M

Call Options Held

Put Options Held

View Full List

About ProPhase Labs, Inc.

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $10.1M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

More about PRPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Pro Phase Labs, Inc. Transaction History